Literature DB >> 1404475

A prognostic role for ceruloplasmin in the diagnosis of indolent and recurrent inflammation.

R K Natesha1, R Natesha, D Victory, S P Barnwell, E L Hoover.   

Abstract

Ceruloplasmin is increased in infections, inflammatory diseases, and neoplastic diseases and may be scarcely visible to the naked eye because it imparts a faint green color to the serum. This poses an interesting question as to a possible prognostic role for ceruloplasmin in the diagnosis of persistent or recurrent infection. The clinical course of 50 patients with tainted serum was reviewed retrospectively and ceruloplasmin levels correlated with diagnosis and outcome. Group I consisted of 20 healthy controls with normal ceruloplasmin levels: 35.1 +/- 2.0 mg/dL (range 25 to 45 mg/dL). Group II was made up of 23 surgical patients; 10 of these patients had elevated levels of ceruloplasmin, nine of whom had significant infections (64.2 +/- 3.2 mg/dL), and one patient was on estrogen (73.7 mg/dL). Group III consisted of 27 medical patients; 25 of these patients had elevated levels of ceruloplasmin, 20 of whom had infections (54.1 +/- 2.6 mg/dL), and five had malignancies (61.0 +/- 3.0 mg/dL). Ceruloplasmin levels were consistently elevated in all patients with infections relative to controls (P less than .001) with a variable response in other disease states. Therefore, ceruloplasmin may be useful as a serum marker for indolent or recurrent infections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1404475      PMCID: PMC2571777     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  3 in total

1.  Changes in serum copper and serum ceruloplasmin concentration induced by surgical trauma.

Authors:  T Hallböök; H Hedelin
Journal:  Acta Chir Scand       Date:  1980

2.  Postoperative changes in serum copper value.

Authors:  G C Gregoriadis; N S Apostolidis; A N Romanos; T P Paradellis
Journal:  Surg Gynecol Obstet       Date:  1982-02

Review 3.  Caeruloplasmin: physiological and pathological perspectives.

Authors:  J M Gutteridge; J Stocks
Journal:  Crit Rev Clin Lab Sci       Date:  1981       Impact factor: 6.250

  3 in total
  7 in total

1.  Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates.

Authors:  Paola Loria; Amedeo Lonardo; Francesca Leonardi; Cristina Fontana; Lucia Carulli; Anna Maria Verrone; Andrea Borsatti; Marco Bertolotti; Fabio Cassani; Alberto Bagni; Paolo Muratori; Dorval Ganazzi; Francesco B Bianchi; Nicola Carulli
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

2.  Free radicals and antioxidant status in chronic osteomyelitis patients: a case control study.

Authors:  Abha Jyoti; Saurababh Singh; Bedabrata Mukhopadhyay; Roshni Gavel; Surendra Pratap Mishra
Journal:  J Clin Diagn Res       Date:  2015-04-01

3.  Determination of Serum Ceruloplasmin Concentration in Patients with Primary Open Angle Glaucoma with Cataract and Patients with Cataract Only: A Pilot Study.

Authors:  Monika Sarnat-Kucharczyk; Wojciech Rokicki; Jolanta Zalejska-Fiolka; Dorota Pojda-Wilczek; Ewa Mrukwa-Kominek
Journal:  Med Sci Monit       Date:  2016-04-25

4.  Ceruloplasmin is a potential biomarker for aGvHD following allogeneic hematopoietic stem cell transplantation.

Authors:  Meng Lv; Hai-ge Ye; Xiao-su Zhao; Xiang-yu Zhao; Ying-jun Chang; Dai-hong Liu; Lan-ping Xu; Xiao-jun Huang
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

Review 5.  Pathogenic adaptations to host-derived antibacterial copper.

Authors:  Kaveri S Chaturvedi; Jeffrey P Henderson
Journal:  Front Cell Infect Microbiol       Date:  2014-02-03       Impact factor: 5.293

6.  Cupric yersiniabactin is a virulence-associated superoxide dismutase mimic.

Authors:  Kaveri S Chaturvedi; Chia S Hung; Daryl E Giblin; Saki Urushidani; Anthony M Austin; Mary C Dinauer; Jeffrey P Henderson
Journal:  ACS Chem Biol       Date:  2013-12-11       Impact factor: 5.100

7.  Single-cell transcriptomic atlas of primate cardiopulmonary aging.

Authors:  Shuai Ma; Shuhui Sun; Jiaming Li; Yanling Fan; Jing Qu; Liang Sun; Si Wang; Yiyuan Zhang; Shanshan Yang; Zunpeng Liu; Zeming Wu; Sheng Zhang; Qiaoran Wang; Aihua Zheng; Shuguang Duo; Yang Yu; Juan Carlos Izpisua Belmonte; Piu Chan; Qi Zhou; Moshi Song; Weiqi Zhang; Guang-Hui Liu
Journal:  Cell Res       Date:  2020-09-10       Impact factor: 46.297

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.